Home » Uncategorized » News digest #261 – Synthetic biology in China, space, CRISPR babies, Pivot’s field day, Culture Biosciences $5.5M

News digest #261 – Synthetic biology in China, space, CRISPR babies, Pivot’s field day, Culture Biosciences $5.5M

News digest 2018
SynBioBeta Digest

News, trends, and stories from the synthetic biology industry

Hi all,

With grand ambitions and serious government backing, China is poised to become a synthetic biology powerhouse, as well as a vast new market for biological engineering tools and resources. One company is establishing itself as a key provider of synthetic biology products and services in China.

Scientists continue to grapple with the news that CRISPR twins were born in China. The revelation intensified the debate about human gene editing, and rightly so. SynBioBeta contributor Fiona Mishel provides the latest on this story, and argues that we must not only understand how CRISPR can used, but also how best to use it.

China has also been making significant progress in the space race recently: NanoRacks launched the historic, first-ever, commercial Chinese experiment to the International Space Station. Launched in June 2017, the experiment (which was recently published in Acta Astronautica) was an educational project from the Beijing Institute of Technology and studied the effects of the space radiation environment on DNA and the changes in mutation rates while in microgravity. Lead scientist Professor Yulin has been conducting innovative DNA research for years. In line with their mission to democratize access to space, NanoRacks followed complete U.S. government compliance in the launch of this experiment.

In ag news, Pivot Bio is disrupting the N fertilizer industry with the release of PROVEN™, their sustainable nitrogen-producing microbe for corn. In trials last year, farmers using this flagship product had a 7.7 bushel per acre advantage over chemical fertilizers in all sorts of weather in 13 different states and 47 different soil types.

Karsten Temme, CEO and co-founder of Pivot Bio, said: “The $212 billion fertilizer industry has essentially remained unchanged for 100 years, until now. For the first time, there’s a better alternative.”

If you’ve been waiting to take our course “introduction to synthetic biology” online – then now’s your chance. Join us live via Zoom on Feb 28th. You can sign up here.

Society struggles to find new natural products, according to Zachary Sun, Tierra Biosciences’ CEO. To learn about how they are using cell-free technology and Labcyte’s Echo Liquid Handler to disrupt natural product discovery, sign up for our webinar on February 27 at 10am Pacific.

Have a great week!
John

Latest news

Biotech firms develop RNAi-based products for pest control

Read more →

 

Culture Biosciences secures $5.5M to pioneer biomanufacturing-as-a-service

Read more →

Pro-GMO chocolate brand launches to demystify GMO farming

Read more →

IDT backs innovative synthetic biology start-ups with grant awards

Read more →

 

Amino Labs and MindFuel to scale synthetic biology education for K-12

Read more →

Amprologix secures funding to develop new antibiotic with Ingenza

Read more →

More reads

More reads

University of California to be granted pioneering CRISPR patent (Reuters)
 

Codexis secures multi-year technology upgrade package for its CodeEvolver protein engineering platform license with Merck (Press release)
 

CHAIN wins grants to deliver new live biotherapeutic products (Press release)
 

Cibus launches new seed brand Falco™, bringing change and choice to North American canola growers (Press release)
 

Twist Bioscience announces appointment of Martin Kunz as Senior Vice President, Operations (Press release)

Apply now for the CSHL Synthetic Biology Course, July 23 – August 5, 2019
 

Travel stipends to attend NSF Workshop learn.design.compute with bio, April 25-27, 2019, in Philadelphia
 

Global Bioenergies: First production of isobutene from wheat straw at demo scale (Press release)
 

Genome editing firm EdiGene raises $10M in series pre-B plus financing round (Genome Web)
 

New CRISPR fight: Old friends Intellia, Caribou in license dispute (Xconomy)
 

Here’s why Amyris is soaring today (The Motley Fool)

Who's hiring?

Who’s hiring?

Senior Strain Engineer: Bondi Bioworks – Sydney, Australia
 

Research Associate (CRISPR): Mammoth Biosciences, San Francisco CA
 

Senior Analytical Chemist / Biochemical Engineer: Bondi Bioworks – Sydney, Australia
 

Scientific Consultant/Senior Scientific Consultant: Riffyn, Oakland, CA
 

Scientist I, Molecular Diagnostics Platform Innovation: CRISPR diagnostics startup
 

Fermentation Research Associate: Conagen, Bedford, MA
 

Analytical Scientist: Conagen, Bedford, MA
 

Scientist/ Scientist Associate – Natural Product Downstream Purification & Analysis: Conagen, Bedford, MA

Scientist (CRISPR): Mammoth Biosciences, San Francisco CA
 

Strain Engineer / Molecular Biologist: Bondi Bioworks – Sydney, Australia
 

VP of Engineering: Riffyn, Oakland, CA
 

Senior Synthetic Biology Scientist: Rejuvenate Bio, San Diego, CA
 

Senior Front End Engineer: Riffyn, Oakland, CA
 

Sr. Research Associate/Scientist – Microbial Synthetic Biology: Conagen, Bedford, MA
 

Automation Associate – Synthetic Biology Automation: Conagen, Bedford, MA
 

Automation Engineer – Synthetic Biology Automation: Conagen, Bedford, MA

Feature your job here →
 
 

Stay updated on the latest news in synthetic biology

Join our weekly newsletter

Sign up

Job opportunities

More